ANDECALIXIMAB
UNII 571045EIM4

Substance Identification & Data

This profile provides standardized clinical and technical data for Andecaliximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 571045EIM4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1518996-49-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

571045EIM4

CAS Registry Number

1518996-49-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANDECALIXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C105803

National Cancer Institute reference terminology for clinical and research data.

INN ID

10035

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-49

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Andecaliximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANDECALIXIMAB

Common Names & Synonyms

ANDECALIXIMAB [INN]

ANDECALIXIMAB [USAN]

ANDECALIXIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(HUMAN GELATINASE B) (HUMAN-MUS MUSCULUS MONOCLONAL GS-5745 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GS-5745 LIGHT CHAIN, DIMER

SYS